These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 4318535)

  • 1. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.
    Dolby JM; Dolby DE
    Immunology; 1969 Jun; 16(6):737-47. PubMed ID: 4306784
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B. pertussis in Czechoslovakia in the years 1966-1970.
    Maixnerová M; Burianová-Vysoká B; Stránský V
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):267-72. PubMed ID: 4342922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic findings in oral pertussis vaccination].
    Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
    Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of Bordetella pertussis antibodies by the latex slide test in comparison to agglutination and complement fixation test].
    Mochmann H; Hering L
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):143-8. PubMed ID: 4297441
    [No Abstract]   [Full Text] [Related]  

  • 11. [Passive protection tests in the mouse with pertussis immunoglobulin (author's transl)].
    Sabin S; Schwanig M
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):268-74. PubMed ID: 228513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype specificity of vaccine-induced immunity to pertussis.
    Preston NW; Carter EJ
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
    Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological surveys of antibodies against B. pertussis and B. parapertussis in some African and Asian countries.
    Maixnerova M; Buriánová B; Teplý V; Pecenka J; Serý V; Jezek Z
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):201-11. PubMed ID: 231624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis serotypes in a whooping cough outbreak.
    Aftandelians RV; Connor JD
    Am J Epidemiol; 1974 May; 99(5):343-6. PubMed ID: 4363474
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 17. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological types of whooping cough bacteria and their connection with immunity in vaccinated children.
    Demina AA; Devyatkina NP; Voloshina LZ; Larina LI; Semina NA; Venglinskaya EA; Kostyukova KP
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):304-15. PubMed ID: 4355335
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory correlates of protection and protective immunity to Bordetella pertussis.
    Shahin RD; Mink C; Wiedermann BL; Meade BD
    Adv Exp Med Biol; 1992; 327():287-92. PubMed ID: 1295347
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitoxin in human pertussis immune globulins.
    Ferngren H; Granström M
    J Biol Stand; 1986 Oct; 14(4):297-303. PubMed ID: 2881931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.